Bull of the Day: NeoGenomics (NEO)

NeoGenomics (NEO) is a small-cap provider of cancer genetics diagnostics. They boast one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat …

NEO Feb 2024 22.500 call

An Interesting Mid Cap Stock and a Small-Cap Provider of Cancer Genetics Diagnostics for Your Consideration. NeoGenomics and Marvell Technology are part of the Zacks Bull and Bear of the Day article.

NEO Aug 2024 12.500 put

An Interesting Mid Cap Stock and a Small-Cap Provider of Cancer Genetics Diagnostics for Your Consideration. NeoGenomics and Marvell Technology are part of the Zacks Bull and Bear of the Day article.